Background: Studies in male combat veterans have suggested posttraumatic stress disorder (PTSD) is associated with shorter telomere length (TL). We examined the cross-sectional association of PTSD with TL in women exposed to traumas common in civilian life.
INTRODUCTION
Posttraumatic stress disorder (PTSD), characterized by severe distress in response to trauma exposure, is associated with incident chronic disease, including cardiovascular disease (CVD) and type 2 diabetes (Lee et al., 2016; Roberts et al., 2015; Sumner et al., 2015) , as well as disease progression (Gander & von Kanel, 2006; Révész, Milaneschi, Verhoeven, & Penninx, 2014) and earlier mortality (Boscarino, 2006) .
Telomere erosion has been proposed as a potentially important mechanism by which traumatic stress and the severe distress that often follows is biologically embedded, resulting in accelerated aging, Psychosocial stress and distress are hypothesized to accelerate telomere erosion via chronic activation of relevant biological processes, including oxidative stress, inflammation, and decreased telomerase activity (Epel et al., 2004) . Empirical work generally finds shorter TL associated with measures of stress or distress, including perceived stress (Epel et al., 2004; Parks et al., 2009) , psychosomatic distress (Zahran et al., 2015) , and salivary biomarkers of stress (Zahran et al., 2015) (although studies are not uniformly consistent (Jodczyk, Fergusson, Horwood, Pearson, & Kennedy, 2014; Savolainen, Eriksson, Kajantie, Lahti, & Räikkönen, 2015; Verhoeven, van Oppen, Puterman, Elzinga, & Penninx, 2015) ), suggesting that telomere shortening may be one mechanism by which PTSD leads to increased risk of disease and premature death.
Seven empirical studies have examined the association of PTSD with leukocyte TL (Boks et al., 2015; Jergović et al., 2014; Ladwig et al., 2013; Malan, Hemmings, Kidd, Martin, & Seedat, 2011; O'Donovan et al., 2011; Shalev et al., 2014; Zhang et al., 2014) . Three studies were conducted with male combat veterans (Boks et al., 2015; Jergović et al., 2014; Zhang et al., 2014) ; two found PTSD associated cross-sectionally with shorter telomeres (Jergović et al., 2014; Zhang et al., 2014) and one found no association (Boks et al., 2015) . Only two studies used population-based samples, and findings were mixed.
One examined TL in association with any internalizing disorder, measured by combining PTSD with generalized anxiety disorder, overanxious disorder of childhood, and depression (Shalev et al., 2014) . This study found significantly shorter TL and more rapid telomere erosion over time among men with versus without any internalizing disorders, but no associations were evident in women. The only populationbased study (among 3,000 German men and women) that examined PTSD specifically reported that participants with versus without PTSD had shorter TL (Ladwig et al., 2013) . A recent meta-analysis considering six of the studies reported a medium to large effect that was significant with a pooled Cohen's d 0.76 (95% confidence interval (CI) = 0.25-1.28) (Lohr et al.) . An additional meta-analysis including five of these studies found a mean difference of −1.27 standard deviations in TL for participants with versus without PTSD (Darrow et al., 2016) .
Current knowledge of the association of PTSD and TL has several limitations. There is ongoing uncertainty whether health-related effects of PTSD are largely due to effects of trauma or to the resultant psychological distress, and few studies of TL have separately examined the effects of trauma versus psychological sequelae of trauma (Tyrka et al., 2016) . If effects are primarily due to trauma, then in fact type of trauma may matter with regard to linkages with TL. While PTSD is more prevalent among women (Tolin & Foa, 2006) , only three studies have been able to consider associations of PTSD and TL among civilian women exposed to traumatic stressors common in everyday life (Ladwig et al., 2013; O'Donovan et al., 2011; Shalev et al., 2014) . Finally, in most studies relevant health risk factors and conditions linked to both PTSD and TL have not been considered. Only two studies considered some relevant health risk factors and conditions linked to both PTSD and TL and conceptualized them as potential confounders (Ladwig et al., 2013; Shalev et al., 2014) . In prior work PTSD has predicted health risk factors and conditions, including elevated BMI (Kubzansky et al., 2014) , smoking (Cook, Jakupcak, Rosenheck, Fontana, & McFall, 2009; Fu et al., 2007) , unhealthy diet (Breslau, Davis, Peterson, & Schultz, 1997; Hall, Hoerster, & Yancy, 2015) , as well as hypertension (Kibler, Joshi, & Ma, 2009 ) and high cholesterol (Heppner et al., 2009; Kulenovic, Kucukalic, & Malec, 2008) , that have been associated with shorter TL (Buxton et al., 2011; Cherkas, Hunkin, & Kato, 2008; Du et al., 2012; Harris et al., 2006; Harris, Martin-Ruiz, von Zglinicki, Starr, & Deary, 2012; Valdes et al., 2005) .
The present study examines the association of PTSD symptoms with TL in a sample of civilian women exposed to stressors common in civilian life. Based on prior work examining PTSD in relation to CVD risk reporting a dose-response relation (Kubzansky, Koenen, Jones, & Eaton, 2009; Kubzansky, Koenen, Spiro, Vokonas, & Sparrow, 2007; Sumner et al., 2015) , we hypothesized subclinical PTSD symptomatology would be associated with shorter TL and that PTSD symptom count would demonstrate a dose-response relation with TL. We examine whether higher prevalence of health risk factors in women with PTSD might account for an association of PTSD with TL, including BMI (Buxton et al., 2011; Kim et al., 2009; Nordfjäll et al., 2008) , smoking (McGrath, Wong, Michaud, Hunter, & De Vivo, 2007; Valdes et al., 2005) , alcohol consumption (Pavanello et al., 2011) , antidepressant use, type 2 diabetes, hypertension (Lung, Ku, & Kao, 2008) , physical activity (Du et al., 2012; Savela et al., 2013) and high cholesterol (Strandberg et al., 2011; Sun et al., 2012) . We investigate the association of type of trauma exposure with TL, and whether type of trauma exposure accounts for possible differences in TL by PTSD status. Moreover, as depression and PTSD are highly comorbid (Bleich, Koslowsky, Dolev, & Lerer, 1997; Campbell et al., 2007; Gill, Page, Sharps, & Campbell, 2008) , and depression is associated with shorter TL in several (Hartmann, Boehner, Groenen, & Kalb, 2010; Schutte & Malouff, 2015; Simon et al., 2006) but not all studies (Ladwig et al., 2013) , we explore the possibility that having PTSD and depression combined is associated with even shorter TL compared with only PTSD.
MATERIALS AND METHODS

Sample
The Nurses' Health Study II (NHSII) comprises 116,430 female nurses enrolled in 1989 at ages 25-42 years and followed biennially. Blood was collected in 1996-1999 when women were ages 32-52 years (Tworoger, Sluss, & Hankinson, 2006) . In 2008, the PTSD substudy was conducted Roberts et al., 2012) . A total of 60,804 NHSII participants were mailed a supplementary questionnaire that assessed trauma exposure and PTSD symptoms; 54,224 participants returned the questionnaire (response rate = 89%); 80% reported at least one lifetime traumatic event, 53% of whom agreed to be interviewed in depth and from whom 2,112 probable cases of PTSD and 2,001 matched controls (all trauma exposed), were identified.
Seventy-three percent of these women (N = 3,013) completed a PTSD diagnostic interview. The protocol has been published ). The present analyses include women who completed the PTSD diagnostic interview and who also served as medically healthy controls in other NHSII substudies that measured TL. One case-control study was for type 2 diabetes (n = 74) and the other was for CVD (n = 24); TL measures were available in an additional sample of healthy women selected for another NHSII substudy because they were exposed to childhood abuse (n = 20) (Mason, Prescott, Tworoger, DeVivo, & RichEdwards, 2015) .
PTSD assessment
Lifetime PTSD case status and PTSD symptom counts were ascertained via diagnostic telephone interview, previously validated against the Clinician-Administered PTSD Scale (Blake et al., 1998) in another cohort (Uddin et al., 2010) . Respondents were asked to identify events they had experienced from a list of 25 potentially traumatic events (e.g., natural disaster, mugging) as well as "any other very stressful situation or event". Respondents then selected the event they considered to be their worst and reported the year it occurred. For analyses considering trauma type explicitly, based on research regarding trauma severity (Roberts et al., 2012) , we grouped worst trauma types in five categories: (1) rape; (2) interpersonal violence; (3) other event to self; (4) sudden death of a loved one; (5) other event to a loved one.
To be a PTSD case, respondents must have experienced their worst trauma before the blood draw and met all DSM-IV criteria for PTSD, as assessed according to 17 symptoms reflecting reexperiencing of the trauma, avoidance/numbing, arousal, and several additional questions (Kessler & Ustun, 2004) . Participants were cued to think of the period following the event during which symptoms were most intense, and then asked whether they had ever been bothered by each of the 17 symptoms (rated each on a scale from 1:"not at all" to 5:"extremely").
Respondents were classified as a PTSD case if they reported experiencing one or more of the five reexperiencing symptoms, three or more of the seven avoidance/numbing symptoms, and two or more of the five arousal symptoms at least "moderately." Additional questions assessed the other three DSM-IV criteria: intense fear, horror, or helplessness in response to the event, symptom duration of at least one month, and clinically significant impairment in functioning due to symptoms.
To assess reliability, a blind review of audiotapes from 50 interviews was conducted by a licensed clinical psychologist who is an experienced diagnostician specializing in PTSD treatment. Reliability was assessed by comparing this diagnosis with that made via computer algorithm from the structured interviews using Cohen's kappa statistic. The kappa was 1.0 (perfect reliability).
Respondents were considered affected by lifetime PTSD if all six DSM-IV criteria were met. Respondents were considered as having subclinical PTSD symptoms if they did not meet all diagnostic criteria and met at least one of the DSM-IV criteria: reexperiencing (≥1 symptom at least "moderately"), avoidance/numbing (≥3 symptoms at least "moderately"), or arousal (≥2 symptoms at least "moderately"), or had clinically significant impairment (McLaughlin et al., 2015) . All other respondents were considered as not having PTSD. We additionally summed PTSD symptoms to create a continuous score (possible range, 17-85) (Solovieff et al., 2014) and divided this score into quintiles to examine a possible dose-response between PTSD symptoms and TL. We included in our analyses only women who reported the year of their worst event as before their blood draw. Women with no or few symptoms comprised the reference group but because few women were eligible, to enlarge this group, we included women whose worst trauma followed the blood draw but who reported low levels of PTSD symptoms (in the lowest PTSD symptom quintile).
Our diagnostic interview also assessed lifetime depression and age of first onset via a modified version of the Patient Health Questionnaire (PHQ-9) using DSM-IV coding criteria (Kroenke, Spitzer, & Williams, 2001 ). Participants were considered as having depression if they met criteria for major depressive disorder and reported onset before the year of their blood draw. The PHQ-9 has excellent internal consistency ( = .87). We ascertained the validity of our mental health assessments in a separate cohort, the Detroit Neighborhood Health Study, via clinical interviews among a random subsample of 51 participants (Uddin et al., 2010) . A licensed psychologist conducted 1-hour in-person interviews, using the Clinician-Administered PTSD Scale for DSM-IV to evaluate PTSD (Blake et al., 1998) and the Structured Clinical Interview for DSM-IV Disorders to evaluate depression (First, Spitzer, Gibbon, & Williams, 1996) . The psychologist was blinded to information obtained from the main study. Comparison of the clinical interviews with the PCL-C and PHQ-9 from the main study showed excellent concordance for both disorders (Uddin et al., 2010) .
Telomere assay
Procedures for telomere assays in NHS samples have been described elsewhere (McGrath et al., 2007) . Briefly, genomic DNA was extracted from peripheral blood leukocytes using the QIAmp (Qiagen) 96-spin blood protocol. PicoGreen DNA quantitation was conducted using a Molecular Devices 96-well spectrophotometer. Genomic DNA was subsequently dried down and resuspended. Telomere repeat copy number to single gene copy number (T/S) was determined by a modified version of the quantitative real-time PCR telomere assay run on Applied Biosystems 7900HT PCR System (Foster City, CA).
Triplicate reactions of each assay were done on each sample. Relative telomere length (RTL) is reported as the exponentiated T/S ratio. The coefficient of variation (CV) for the exponentiated T/S ratio of blinded quality control samples was 23% for T2DM cases and controls and 33% for CVD cases and controls. Within-replicate CVs for participants and blinded QCs were lower within plates, ranging from 10.7 to 19.4%.
Further, after excluding QC samples with within-triplicate CVs > 20%, CVs dropped to 14-26%. Finally, nonblinded laboratory QCs were also included across plates and CVs in these samples averaged 11.5%. Overall, these results suggest most variation occurred between batches.
Because the RTL deviated significantly from normality, we took the log to derive a normally distributed outcome. To control for variation across laboratory batches, we used the Rosner batch-correction method (Rosner, Cook, Portman, Daniels, & Falkner, 2008) as follows.
First, we regressed log-RTL on indicators for laboratory batch and potential predictors of RTL that might vary by batch, including participant's year of birth; father's age at birth; and age, smoking status (never/past/current), and BMI at time of blood draw. We calculated a correction parameter for each batch by subtracting the average of all batch parameter estimates from the parameter estimate for each individual batch. For each observation assayed within a particular batch, we produced a batch-adjusted log-RTL (henceforth simply log-RTL) by adjusting the log-RTL by subtracting that batch's correction parameter.
Covariates
To ensure each covariate measured circumstances following PTSD onset and before the blood draw, we used covariates queried on a questionnaire given with the blood draw and on the closest preceding biennial questionnaire (1995), as available. Age at blood draw was determined from self-reported birthdate. BMI was self-reported on the blood draw questionnaire. Self-reported BMI has been validated in the Nurses' Health studies (Rimm et al., 1990) . Past-month smoking was reported on the blood draw questionnaire as: none, 1-4, 5-14, 15-24, 25-34, 35-44, or ≥45 cigarettes/day. Smoking history was taken from prior questionnaires to characterize smoking at the blood draw as: current, former, or never. Diet was characterized from responses to a validated food frequency questionnaire (Willett et al., 1988) 
Statistical analyses
To examine the characteristics of the sample, we calculated means and standard deviations for age and BMI and prevalence of smoking, alcohol consumption, healthy diet, physical activity, antidepressant use, high blood pressure, and high cholesterol by PTSD status. We also examined characteristics of trauma exposure by PTSD status.
To ascertain whether log-RTL was shorter among women with PTSD, we first calculated mean log-RTL by PTSD diagnostic category and then fitted a linear regression model with log-RTL as the dependent variable and PTSD status as the independent variable. Age was only weakly associated with log-RTL in this sample ( = .003; 95% CI = 0.005, 0.010; P = .52), and a model of RTL with age and age-squared had better fit than a model with age alone according to Akaike information criteria; thus, we included age and age-squared in all models. To investigate whether lifestyle factors might account for possible shorter telomeres in women with PTSD, we examined the association of each lifestyle factor with log-RTL and examined the association of PTSD with log-RTL in models with and without the lifestyle factor, adjusted for age and age-squared. As our sample size was moderate, to avoid overfitting we included only lifestyle factors that were either associated with log-RTL at P < .10 or that altered the association of PTSD with log-RTL by ≥10%. We then fit a model with log-RTL as the dependent variable and PTSD status as the independent variable further adjusted for all lifestyle factors meeting at least one of these criteria.
We also examined log-RTL in association with a continuous measure of PTSD symptoms, and examined the impact of lifestyle factors similarly to the models with PTSD diagnostic category.
To understand whether characteristics of trauma exposure accounted for possible associations of PTSD with log-RTL, we examined the association of worst trauma type with log-RTL and the association of PTSD with log-RTL adjusted for type of worst trauma.
We further examined whether age at worst trauma was associated with log-RTL. Age at worst trauma and age at blood draw were moderately correlated (Pearson correlation coefficient = 0.15). All models adjusted for age at blood draw and age-squared.
To determine whether telomeres were further shortened among women with both PTSD and depression, we created a categorical variable coded as: no PTSD or depression, no PTSD with depression, subclinical PTSD only, subclinical PTSD with depression, PTSD diagnosis only, and PTSD diagnosis with depression, and calculated mean log-RTL for each level of this categorical variable. We modeled log-RTL as the dependent variable with major depression, PTSD diagnosis and their interaction term as independent variables.
We conducted three sensitivity analyses, by: (1) including cases in addition to controls from the diabetes and CVD studies; (2) excluding women selected on the basis of childhood abuse (although childhood abuse is not associated with log-RTL in this cohort ); (3) excluding women whose worst trauma followed the blood draw but who reported low levels of PTSD symptoms. For all models we used PROC GENMOD in SAS 9.4 (SAS Institute, Cary, NC) with an identity link and a normal distribution to estimate regression coefficients and 95% CIs.
RESULTS
Women with PTSD had slightly higher BMI (28.4 vs. 25.1 kg/m 2 ) and were more likely to use antidepressants regularly (52.0 vs. 10.7%) at the time of the blood draw compared with women without PTSD (Table 1) . For worst trauma type, among women without PTSD, sudden death of a loved one was the most prevalent category (40.0%), and among women with PTSD, other trauma to self (28.0%), rape (24.0%), and interpersonal violence (24.0%) were most prevalent (Table 2) .
PTSD diagnosis was associated with shorter log-RTL (Figure 1 ).
After adjusting for age at blood draw, PTSD diagnosis remained associated with shorter log-RTL (Table 3 , Model 1a). Subclinical PTSD versus no PTSD was associated with shorter log-RTL, but this difference did not reach statistical significance. In this sample, BMI and smoking, but none of the other health-related covariates, were associated with log-RTL (P < .10). In age-adjusted models, diet and a Respondents were considered to have subclinical PTSD symptoms if they did not meet diagnostic criteria for PTSD and met at least one of the DSM-IV reexperiencing, avoidance/numbing, or arousal criteria or had clinically significant impairment. b Women whose worst event followed the blood draw and who had very few PTSD symptoms from that event were included in this group. Therefore, the range includes negative numbers, corresponding to worst events that followed the blood draw.
F I G U R E 1 Mean log relative telomere length by PTSD status and trauma exposure antidepressant use altered the association of PTSD with log-RTL by ≥10%. We therefore included BMI, smoking, diet and antidepressant use as covariates. Including these lifestyle factors (Table 3, Model 2a) did not substantially attenuate the association between PTSD diagnosis and shorter log-RTL. Results were similar when examining PTSD symptoms as a continuous variable (Table 3 , Models 1b-2b).
Worst trauma type was not associated with log-RTL in a model adjusted for age at blood draw (Wald chi-sq df = 4 = 6.3, P = .18). PTSD diagnosis remained associated with log-RTL in models further adjusted for worst trauma type (Table 3 , Models 3a and 3b) and also when further adjusted for age at worst trauma (Wald chi-sq df = 1 = 4.0, P = .047).
To further explore these findings, we restricted to women with subclinical PTSD or PTSD diagnosis and again examined whether trauma type was associated with log-RTL. In this subgroup, type of trauma was not associated with log-RTL (df = 4, chi-square = 4.21, P = .38).
PTSD in conjunction with depression was not associated with significantly different log-RTL than PTSD alone (PTSD × depression interaction term, P = 0.44, Table 4 ). To further explore the association of PTSD, depression and log-RTL, we fitted a model of log-RTL with both PTSD and depression as independent variables, adjusted for age and age- 
DISCUSSION
In this analysis of trauma-exposed women, PTSD diagnosis and PTSD symptoms were associated with shorter telomeres. Prior studies with male combat veterans (Jergović et al., 2014; Zhang et al., 2014) have similarly found PTSD associated with shorter telomeres. Our study extends these findings to women in the general population. Moreover, we examined a wide variety of health indicators and health-related behaviors that may account for the PTSD-TL association; we found no evidence that these factors played a role in our finding of shorter telomeres among women with PTSD. This suggests that if PTSD has a causal effect on TL, it may operate through other mechanisms. Only one previous study has examined health behaviors and conditions as factors that may explain the association between PTSD and TL (Ladwig et al., 2013) . This study also found an inverse association of PTSD with TL and found that health behaviors (smoking, BMI, alcohol consumption) and conditions (hypertension) did not account for the association (Ladwig et al., 2013) . Similarly, in the study examining internalizing disorders (including PTSD), smoking, substance dependence, psychiatric medication use, poor physical health, low socioeconomic status, and childhood maltreatment did not account for shorter telomeres in participants with internalizing disorders (Shalev et al., 2014) .
We further found that type of trauma exposure was not associated with TL and accounted for very little of the association of PTSD with TL.
Prior studies examining associations of trauma exposure with TL have mostly focused on childhood abuse, with mixed findings. While several have found shorter telomeres associated with a history of childhood abuse (O'Donovan et al., 2011; Shalev et al., 2013; A. R. Tyrka et al., 2010) , three of the larger studies found no association (Glass, Parts, Knowles, Aviv, & Spector, 2010; Mason et al., 2015; Verhoeven et al., 2015) . Only one of these studies also considered PTSD, finding that childhood abuse accounted for the association of PTSD with shorter telomeres (O'Donovan et al., 2011). A Dutch study of TL before and after military deployment found no difference in change in TL between men who were exposed to high versus low levels of combat trauma (Boks et al., 2015) . This study additionally examined childhood trauma, and found no association of childhood trauma with TL or with change in TL over time. It is possible that the mixed findings in these studies, and our own finding of no association between trauma type and TL, is partly due to imprecise measurement of the extent and severity of trauma exposure across the life course.
Among women with PTSD or subclinical PTSD, we found cooccurring depression was not associated with significantly shorter telomeres. As group sizes were small when examining PTSD with and without depression, a larger study may be needed to identify a potential joint effect of PTSD and depression on TL. In models mutually adjusted for PTSD and depression, PTSD diagnosis-and not depression-was significantly associated with shorter telomeres.
These results concur with findings that greater overall level of psychopathology may be associated with shorter TL (Bersani et al., 2016; Darrow et al., 2016) .
Our findings are subject to several limitations, including a moderate sample size and assessment of relative versus absolute TL, possibly resulting in greater measurement error. Although TL of women with PTSD were statistically significantly shorter than TL of women without PTSD, CIs overlapped, thus results should be interpreted cautiously. PTSD symptoms and year of onset were assessed retrospectively, which may have introduced error in PTSD assessment. Study strengths include that PTSD cases and controls were sampled from a well-defined longitudinal cohort, and multiple health factors that may account for the association between PTSD and TL were assessed.
Given that health and health-related behaviors did not explain the association of PTSD with TL, it remains possible that PTSD affects TL through more direct biological pathways. Two such pathways are through increased oxidative stress (Richter & von Zglinicki, 2007; Wilson et al., 2013) and reduced telomerase activity (Epel et al., 2004) .
Persons with PTSD have been found to have lower expression of the antioxidative enzymes thioredoxin reductase and the superoxide dismutases (Zieker et al., 2007) . Downregulation of these genes could impair oxidative defense mechanisms and result in higher concentrations of reactive oxygen species (Zieker et al., 2007) , potentially leading to telomere erosion (Richter & von Zglinicki, 2007; Wilson et al., 2013) . Life stressors and perceived stress have been associated with lower telomerase activity (Epel et al., 2004; Schutte & Malouff, 2014b) . Moreover, stress management interventions have been associated with increased telomerase activity in the short term (Schutte & Malouff, 2014a) and smaller declines in telomerase activity with ageing (Ornish et al., 2013) . Thus, to the extent there is a causal relationship, PTSD may lead to shorter telomeres via reduced telomerase activity.
Future research with appropriate study designs is needed to strengthen evidence for or against the hypothesis that PTSD causes telomere shortening and that telomere shortening is a mechanism by which PTSD is associated with incident disease. First, if PTSD causally contributes to telomere shortening, one would expect successful PTSD treatment and PTSD remission more broadly would be associated prospectively with smaller declines in TL and possibly increased telomerase activity. Second, prospective studies are needed to determine whether telomere shortening following PTSD onset is a risk factor for subsequent disease incidence. PTSD is an adverse outcome in its own right. However, findings that PTSD may lead to accelerated aging processes suggest PTSD has more far-reaching effects than have previously been appreciated, and have important implications for treatment and prevention of physical health sequelae among individuals with PTSD.
